Trump Blackmailing शुरू। India को फिर किया Target | Nifty के बुरे दिन फिर शुरू?
Trump has announced fresh tariffs on generic drugs — and this time Indian pharma is directly in the firing line. In this video we decode what the announcement actually says, which Indian pharma companies are most exposed, the latest escalation in the Iran conflict, and what today's market data and charts are signalling for Nifty.Last year's pharma tariffs only covered patented and branded drugs, so the impact on India was negligible. Generics were exempt. That exemption has now ended — and generics are India's single largest pharma export to the US.
What's in this video:
Iran war update — US strikes enter an 11th night. Iran claims an attack on a US base in Kuwait; Bahrain, Jordan and Kuwait all report intercepting incoming missiles. Strait of Hormuz traffic has collapsed to just 9 vessels in 24 hours against a pre-conflict average of 120-130 a day. Marco Rubio raised freedom of navigation at ASEAN in Manila. Crude is now above $85 and the rupee has crossed 96 — neither has recovered even after the MoU was signed.
The tariff structure — Zero tariff until July 2028 (a two-year window), then 100% from August 2028, then 200% from 2029 onwards. Trump's stated intention is to reshore generic manufacturing into America, with a penalty for companies that don't build plant and equipment inside that window. Note that 2028 is a US election year.
Why this targets India specifically — India exported $9.7bn of pharma in FY25, roughly 38% of total global pharma exports, and supplies 40-45% of all generic medicine consumed in the US. There's also a second tariff threat coming on Russian oil importers, where India is the second-largest buyer.
Which pharma stocks are most exposed — Ranked by share of revenue earned in the US: Gland Pharma, Aurobindo, Dr Reddy's, Zydus, Lupin and Sun Pharma carry the highest exposure. Cipla and Torrent Pharma are relatively safer, having deliberately built up domestic revenue share.
Market analysis — Nifty broke below 24,000 and closed under it. What lies ahead? Watch this video to know more
━━━━━━━━━━━━━━━━━━━━━━
⏱️ TIMESTAMPS
━━━━━━━━━━━━━━━━━━━━━━
00:00 – Intro: fresh Trump tariff attack
00:37 – Iran war update: 11th night of US strikes
01:35 – Strait of Hormuz traffic collapse
02:26 – Crude above $85, rupee weakness
03:06 – Trump tariffs on generics explained
03:36 – The 0% / 100% / 200% timeline
04:43 – Trump's reshoring intention & pressure tactics
05:26 – The Russian oil tariff threat
06:03 – Why India is hit hardest: the export numbers
07:12 – Bear case: razor-thin generic margins
08:33 – Bull case: negotiation window & 2028 elections
10:07 – BullTrack Stock X-Ray
11:02 – Which pharma companies are most exposed
12:52 – Market data: Nifty, VIX, PCR, futures
14:50 – Chart analysis & key levels
17:10 – Closing thoughts
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
🔥 JOIN BULLTRACK COMMAND
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Tired of trading the headline and getting stopped out? Build the structural edge.
→ Download All New Blltrack App
https://play.google.com/store/apps/details?id=bulltrack.com.optiongreeks13&pcampaignid=web_share
→ BullTrack Edge: Real-time FPI sectoral tracking, derivative dashboard, weekly institutional briefings
→ Try Stock X-Ray Tool: https://www.bulltrack.in/stockxray
→ Subscribe to BullTrack for institutional-grade market analysis made simple
→ Join this channel to get access to perks:
https://www.youtube.com/channel/UCZ33fuWb4BaUuKBSFMAY8nQ/join
→ Bulltrack Portfolio
https://www.bulltrack.in/global
https://www.bulltrack.in/portfolio
→ For Any queries WhatsApp - 99033 22404
→ Subscribe and hit the bell so you don't miss the next forensic breakdown
═══════════════════════════════════════
📊 BullTrack — When Markets Talk, We Translate
═══════════════════════════════════════
ABOUT BULLTRACK:
BullTrack is a SEBI Registered Research Analyst platform delivering institutional-grade market analysis for retail investors. We cover Indian equities, macroeconomics, derivatives, and global market transmission chains with original data-driven frameworks.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
⚠️ SEBI DISCLAIMER & COMPLIANCE NOTE
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
. This video is for educational and informational purposes only and does NOT constitute investment advice or a buy/sell recommendation. All data is from publicly available, named sources and has been independently verified.
#TrumpTariffs #IndianPharma #NiftyAnalysis #StockMarketIndia #PharmaStocks #BullTrack #SunPharma #DrReddys #Aurobindo #Cipla #Lupin #ZydusLifesciences #IranWar #CrudeOil #NiftyPrediction #ShareMarket #StockMarketNews #GenericDrugs #IndianStockMarket #MarketAnalysis Receive SMS online on sms24.me
TubeReader video aggregator is a website that collects and organizes online videos from the YouTube source. Video aggregation is done for different purposes, and TubeReader take different approaches to achieve their purpose.
Our try to collect videos of high quality or interest for visitors to view; the collection may be made by editors or may be based on community votes.
Another method is to base the collection on those videos most viewed, either at the aggregator site or at various popular video hosting sites.
TubeReader site exists to allow users to collect their own sets of videos, for personal use as well as for browsing and viewing by others; TubeReader can develop online communities around video sharing.
Our site allow users to create a personalized video playlist, for personal use as well as for browsing and viewing by others.
@YouTubeReaderBot allows you to subscribe to Youtube channels.
By using @YouTubeReaderBot Bot you agree with YouTube Terms of Service.
Use the @YouTubeReaderBot telegram bot to be the first to be notified when new videos are released on your favorite channels.
Look for new videos or channels and share them with your friends.
You can start using our bot from this video, subscribe now to Trump Blackmailing शुरू। India को फिर किया Target | Nifty के बुरे दिन फिर शुरू?
What is YouTube?
YouTube is a free video sharing website that makes it easy to watch online videos. You can even create and upload your own videos to share with others. Originally created in 2005, YouTube is now one of the most popular sites on the Web, with visitors watching around 6 billion hours of video every month.
